Document is current
Any future updates will be listed below
-
Authors
Peters, Christine E.
Schulze-Gahmen, Ursula https://orcid.org/0000-0003-3919-4474
Eckhardt, Manon https://orcid.org/0000-0001-8143-6129
Jang, Gwendolyn M. https://orcid.org/0000-0001-7806-9874
Xu, Jiewei
Pulido, Ernst H. https://orcid.org/0000-0002-3616-9743
Bardine, Conner
Craik, Charles S. https://orcid.org/0000-0001-7704-9185
Ott, Melanie https://orcid.org/0000-0002-5697-1274
Gozani, Or https://orcid.org/0000-0002-1365-4463
Verba, Kliment A. https://orcid.org/0000-0002-2238-8590
Hüttenhain, Ruth https://orcid.org/0000-0002-0896-5910
Carette, Jan E. https://orcid.org/0000-0002-5187-8070
Krogan, Nevan J. https://orcid.org/0000-0003-4902-337X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (T32 AI00732, U19 AI171110, U19 AI171110, U19 AI171110, R01 AI140186, R01 AI141970, U19 AI171421, R01 AI130123, R01 AI153169, U19 AI171110, P50 AI150476, U19 AI135990)
National Science Foundation (DGE-1656518)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Covid Catalyst Award from the Center for Emerging and Neglected Diseases
Gladstone BioFulcrum Viral and Infectious Disease Research Program
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM139569)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Burroughs Wellcome Fund (Investigators in the Pathogenesis of Infectious Disease)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
- License Information
-
More Information
Article History
Received: 14 June 2022
Accepted: 16 August 2022
First Online: 8 September 2022
Competing interests
: The Krogan laboratory has received research support from F. Hoffmann-La Roche, and the Krogan and Ott laboratories have received research support from Vir Biotechnology. Nevan Krogan has consulting agreements with the Icahn School of Medicine at Mount Sinai, New York, Maze Therapeutics and Interline Therapeutics. He is a shareholder of Tenaya Therapeutics, Maze Therapeutics and Interline Therapeutics, and is financially compensated by GEn1E Lifesciences, Inc. and Twist Bioscience Corp.. Jan Carette has consulted for Janssen BioPharma. Or Gozani is a scientific co-founder, consultant and shareholder of EpiCypher, Inc, and K36 Therapeutics, Inc. The remaining authors declare no competing interests.
